Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a ...

Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

PORTOS can determine which patients with localized prostate cancer will benefit from dose-escalation of radiotherapy, data suggest.

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

Untreated prostate cancer can sometimes cause erectile dysfunction (ED). However, ED is more commonly associated with ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

External beam radiation therapy with or without short-term androgen deprivation showed 15-year survival benefits for ...

Testosterone recovery was associated with improved OS in patients with high-risk prostate cancer treated with ADT and radiotherapy.

A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...